Detalles de la búsqueda
1.
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study.
Lancet
; 402(10400): 451-463, 2023 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423228
2.
Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany.
Mod Pathol
; 30(2): 217-226, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27767099
3.
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade.
Cancer Cell
; 42(3): 429-443.e4, 2024 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366589
4.
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide.
Lung Cancer
; 186: 107418, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931445
5.
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial.
J Immunother Cancer
; 10(2)2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35190375
6.
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide.
J Thorac Oncol
; 17(9): 1122-1129, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764236
7.
Fast progression in non-small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel.
J Immunother Cancer
; 9(3)2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33737340
8.
A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens.
Cancer Cytopathol
; 128(12): 928-938, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32721105
9.
HER2 testing in gastric cancer diagnosis: insights on variables influencing HER2-positivity from a large, multicenter, observational study in Germany.
Virchows Arch
; 474(5): 551-560, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30826877
Resultados
1 -
9
de 9
1
Próxima >
>>